Crestor RUSH (The Efficacy of RosUvaStatin for Korean Dyslipidemia Patients With Hypertension )

AstraZeneca

Status: Completed

Conditions: Hypertension; Dyslipidemia

Study type: Observational

Funder types: Industry

Identifiers

NCT00526708

NIS-CKR-CRE-2007/2

Details and patient eligibility

About

To evaluate the efficacy of rosuvastatin in Korean dyslipidemia patients with hypertension.

Enrollment: 5,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Hyperlipidemia patients who are prescribed with rosuvastatin 10mg, based on clinical grounds and fulfil the following criteria

  1. Over 18 years of age
  2. Currently or previously diagnosed with hypertension and receiving medical care

Exclusion criteria

1. Patients already taking other hyperlipidemic agents
2. Patients who do not fulfil the indication criteria for statin therapy
3. Patients who do not have baseline and/or follow-up lipid data to verify the efficacy data